These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 29758836)

  • 1. Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.
    Burcher S; Meiser B; Mitchell G; Saunders C; Rahman B; Tucker K; Barlow-Stewart K; Watts K; Gleeson M; Kirk J
    Per Med; 2013 Jul; 10(5):431-440. PubMed ID: 29758836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer.
    Watts KJ; Meiser B; Mitchell G; Kirk J; Saunders C; Peate M; Duffy J; Kelly PJ; Gleeson M; Barlow-Stewart K; Rahman B; Friedlander M; Tucker K;
    BMC Cancer; 2012 Jul; 12():320. PubMed ID: 22838957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.
    Douma KF; Meiser B; Kirk J; Mitchell G; Saunders C; Rahman B; Sousa MS; Barlow-Stewart K; Gleeson M; Tucker K
    Fam Cancer; 2015 Jun; 14(2):265-72. PubMed ID: 25391616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
    Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
    Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
    Gleeson M; Meiser B; Barlow-Stewart K; Trainer AH; Tucker K; Watts KJ; Friedlander M; Kasparian N
    Oncol Nurs Forum; 2013 May; 40(3):275-83. PubMed ID: 23619104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.
    Zilliacus E; Meiser B; Gleeson M; Watts K; Tucker K; Lobb EA; Mitchell G
    Support Care Cancer; 2012 Nov; 20(11):2949-58. PubMed ID: 22441502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.
    Hallowell N; Wright S; Stirling D; Gourley C; Young O; Porteous M
    Fam Cancer; 2019 Jul; 18(3):293-301. PubMed ID: 30689103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. There is no decision to make: experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer.
    Meiser B; Gleeson M; Kasparian N; Barlow-Stewart K; Ryan M; Watts K; Menon D; Mitchell G; Tucker K
    Gynecol Oncol; 2012 Jan; 124(1):153-7. PubMed ID: 22032838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'.
    Wright S; Porteous M; Stirling D; Young O; Gourley C; Hallowell N
    Soc Sci Med; 2019 Mar; 225():26-33. PubMed ID: 30784848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.
    Meiser B; Quinn VF; Gleeson M; Kirk J; Tucker KM; Rahman B; Saunders C; Watts KJ; Peate M; Geelhoed E; Barlow-Stewart K; Field M; Harris M; Antill YC; Mitchell G
    Eur J Hum Genet; 2016 Nov; 24(11):1517-1523. PubMed ID: 27329735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
    Quinn VF; Meiser B; Kirk J; Tucker KM; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Cicciarelli L; Crowe K; Bowen MT; Mitchell G
    Genet Med; 2017 Apr; 19(4):448-456. PubMed ID: 27684037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.
    Wright S; Porteous M; Stirling D; Lawton J; Young O; Gourley C; Hallowell N
    J Genet Couns; 2018 May; 27(6):1459-72. PubMed ID: 29752676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.
    Sutherland S; Meiser B; Kaur R; Mitchell G; Kirk J; Peate M; Tim Wong WK; Goodwin A
    Breast J; 2019 Jan; 25(1):34-40. PubMed ID: 30525267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid genetic counseling and testing in newly diagnosed breast cancer: Patients' and health professionals' attitudes, experiences, and evaluation of effects on treatment decision making.
    Wevers MR; Aaronson NK; Bleiker EMA; Hahn DEE; Brouwer T; van Dalen T; Theunissen EB; van Ooijen B; de Roos MA; Borgstein PJ; Vrouenraets BC; Vriens E; Bouma WH; Rijna H; Vente JP; Kuenen MA; van der Sanden-Melis J; Witkamp AJ; Rutgers EJT; Verhoef S; Ausems MGEM
    J Surg Oncol; 2017 Dec; 116(8):1029-1039. PubMed ID: 28703900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivorship care after breast cancer: follow-up practices of Australian health professionals and attitudes to a survivorship care plan.
    Brennan ME; Butow P; Spillane AJ; Boyle FM
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):116-25. PubMed ID: 20565424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.
    Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward RL; Goodwin A; Macrae F; Hiller J; Trainer AH; Mitchell G
    Fam Cancer; 2017 Jan; 16(1):99-109. PubMed ID: 27677266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    Ardern-Jones A; Kenen R; Eeles R
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of Canadian oncology practitioners toward psychosocial interventions in clinical and research settings in women with breast cancer.
    Del Giudice ME; Leszcz M; Pritchard KI; Vincent L; Goodwin P
    Psychooncology; 1997 Sep; 6(3):178-89. PubMed ID: 9313283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of Canadian radiation oncologists towards post-lumpectomy radiotherapy for elderly women with stage I hormone-responsive breast cancer.
    Warner E; Chow E; Fairchild A; Franssen E; Paszat L; Szumacher E
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):97-106. PubMed ID: 19883996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.